by Gi Yeonjin
Published 03 Feb.2021 15:34(KST)
Updated 03 Feb.2021 15:35(KST)
[Asia Economy Reporter Ji Yeon-jin] Jin Biotech announced on the 3rd that its sales revenue last year reached 62.3 billion KRW, an increase of 7.03% compared to the previous year. Operating profit decreased by 88.81% to approximately 900 million KRW, and net loss for the period expanded by 1031% to 300 million KRW.
The company decided to pay a cash dividend of 30 KRW per common share.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.